Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Morrison

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Immunological Reviews|February 28, 2020
Introduction: Evolution of inflammatory arthritis from innate to adaptive immune mechanismsKristine A Kuhn, Thomas E Morrison
Current Opinion in Immunology|December 18, 2020
Editorial overview: At the interface: host-pathogen interactions that dictate protection and pathologyAshley L St John, Thomas E Morrison
Biorxiv : the Preprint Server for Biology|November 14, 2023
Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2Brian C Ware, M Guston Parks, Thomas E Morrison
Future Virology|April 28, 2021
Mechanisms underlying the pathogenesis of arthritogenic alphaviruses: host immune responses and virus persistenceDavid W Hawman, Kristina S Burrack, Thomas E Morrison
Journal of Virology|September 13, 2008
Complement receptor 3 promotes severe ross river virus-induced diseaseThomas E Morrison, Jason D Simmons, Mark T Heise
Molecular Immunology|June 16, 2009
CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoterJillian A Bristol, Thomas E Morrison, Shannon C Kenney
Journal of Virology|December 13, 2003
Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1Thomas E Morrison, Amy Mauser, Aloysius Klingelhutz, et al.
Current Topics in Microbiology and Immunology|January 19, 2019
Chronic Chikungunya Virus DiseaseMary K McCarthy, Bennett J J Davenport, Thomas E Morrison
Vaccines|November 26, 2024
Second-Generation Phage Lambda Platform Employing SARS-CoV-2 Fusion Proteins as a Vaccine CandidateAlexis Catala, Bennett J Davenport, Thomas E Morrison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2014
CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected miceKristina S Burrack, Stephanie A Montgomery, Dirk Homann, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Immunological Reviews|February 28, 2020
Introduction: Evolution of inflammatory arthritis from innate to adaptive immune mechanismsKristine A Kuhn, Thomas E Morrison
Current Opinion in Immunology|December 18, 2020
Editorial overview: At the interface: host-pathogen interactions that dictate protection and pathologyAshley L St John, Thomas E Morrison
Biorxiv : the Preprint Server for Biology|November 14, 2023
Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2Brian C Ware, M Guston Parks, Thomas E Morrison
Future Virology|April 28, 2021
Mechanisms underlying the pathogenesis of arthritogenic alphaviruses: host immune responses and virus persistenceDavid W Hawman, Kristina S Burrack, Thomas E Morrison
Journal of Virology|September 13, 2008
Complement receptor 3 promotes severe ross river virus-induced diseaseThomas E Morrison, Jason D Simmons, Mark T Heise
Molecular Immunology|June 16, 2009
CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoterJillian A Bristol, Thomas E Morrison, Shannon C Kenney
Journal of Virology|December 13, 2003
Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1Thomas E Morrison, Amy Mauser, Aloysius Klingelhutz, et al.
Current Topics in Microbiology and Immunology|January 19, 2019
Chronic Chikungunya Virus DiseaseMary K McCarthy, Bennett J J Davenport, Thomas E Morrison
Vaccines|November 26, 2024
Second-Generation Phage Lambda Platform Employing SARS-CoV-2 Fusion Proteins as a Vaccine CandidateAlexis Catala, Bennett J Davenport, Thomas E Morrison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2014
CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected miceKristina S Burrack, Stephanie A Montgomery, Dirk Homann, et al.
Pageof 13